Recent Blog Articles
Is blood sugar monitoring without diabetes worthwhile?
Large review study finds low risk of erectile dysfunction after prostate biopsy
Does exercise help protect against severe COVID-19?
A new Alzheimer’s drug has been approved. But should you take it?
Need physical therapy? 3 key questions your PT will ask
COVID-19 vaccines: Safe and effective for American Indian and Alaskan Native communities
Should we track all breakthrough cases of COVID-19?
Period equity: What is it, why does it matter?
Common questions about medical cannabis
Mouth-watering summer fruits and vegetables to fill your plate
Heart Health
Promising news about heart failure
Novel drug improves breathing and appears to extend life.
It may be hard to imagine that a drug derived from a hormone associated with pregnancy could improve the symptoms of heart failure, but that's what serelaxin appears to do. In clinical trials of people hospitalized with new onset of sudden (acute) heart failure, the drug significantly improved shortness of breath (a condition doctors call dyspnea), one of the most frightening and persistent symptoms of the disease. It also reduced organ damage caused by poor blood flow and reduced deaths.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
